• Strong revenue growth of 55.6% to $393.5m
• Improved operating EBITDA margin of 20.6% (up 230bps vs 1H FY25)
• Capitol merger annual synergies of $14m+ achieved, materially above expectation

Integral Diagnostics Ltd reported strong financial results for the first half of FY26, with revenue growing 55.6% to $393.5m, operating EBITDA increasing 75.6% to $81.1m, and operating NPAT rising 154.6% to $22.3m. The company highlighted that the strategic benefits from the Capitol merger continue to be realised across teleradiology, procurement, and employee engagement. The Capitol merger annual synergies of over $14m were materially above the initial expectation of $10m. The company also reported a strong balance sheet with reduced leverage of 2.5x at 31 December 2025, and 51.2% of gross debt hedged at favourable interest rates. Operationally, the company delivered excellent clinical outcomes for patients with a Net Promoter Score of 82 in Australia, and continued to grow its teleradiology reporting platform, IDXt, which now has 124 tele-radiologists. The company also invested $24.9m in capital expenditure, including $8m in growth initiatives such as new clinic sites in South Australia, Victoria, and Queensland. Overall, Integral Diagnostics is well-positioned to further support government initiatives and deliver solid revenue growth and margin expansion.